Rivastigmine tartrate 是一种具有口服活性的、可透过血脑屏障的胆碱酯酶抑制剂，能够抑制丁酰胆碱酯酶和乙酰胆碱酯酶。它是一种拟副交感神经剂或胆碱能剂，用于研究轻度至中度阿尔茨海默氏型痴呆和帕金森氏病引起的痴呆。

Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

129101-54-8

C18H28N2O8

400.428

酒石酸卡巴拉汀;SDZ-ENA 713;ENA 713

DMSO:39 mg/mL (97.4 mM)
Ethanol:74 mg/mL (184.8 mM)
H2O:73 mg/mL (182.3 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years